Related Experiment Video
Updated: Feb 9, 2026
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
972
Long Non-Coding RNA CASC2 Improves Diabetic Nephropathy by Inhibiting JNK Pathway
Huihui Yang1, Quan E Kan1, Yong Su1
1Department of Endocrinology, Henan Provincial People's hospital, Zhengzhou City, Henan Province, PR. China.
Summary
Long non-coding RNA CASC2 is reduced in diabetic nephropathy patients. CASC2 may improve diabetic nephropathy by inhibiting the JNK pathway, offering a potential therapeutic target.
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Long non-coding RNA CASC2 (CASC2) is known to inhibit the JNK pathway in certain disease models.
- Activation of the JNK pathway is implicated in the exacerbation of diabetic nephropathy.
- This suggests a potential protective role for CASC2 in diabetic nephropathy via JNK pathway inhibition.
Purpose of the Study:
- To investigate the role of CASC2 in the pathogenesis of diabetic nephropathy.
- To determine if serum CASC2 levels can serve as a biomarker for diabetic nephropathy.
- To explore the mechanistic link between CASC2, JNK pathway, and podocyte injury in diabetes.
Main Methods:
- Serum CASC2 levels were measured in patients with diabetic nephropathy and healthy controls.
- Correlation analysis was performed to assess the relationship between serum CASC2 levels and clinical parameters.
- Receiver Operating Characteristic (ROC) curve analysis was used to evaluate the diagnostic potential of serum CASC2.
- In vitro experiments using mouse podocyte cells treated with high glucose were conducted to assess CASC2 expression, JNK1 phosphorylation, and apoptosis.
Main Results:
- Serum CASC2 levels were significantly lower in patients with diabetic nephropathy compared to controls.
- Serum CASC2 levels correlated with the course of the disease but not with age, gender, alcohol consumption, or smoking habits.
- ROC curve analysis indicated that serum CASC2 is a potential biomarker for diabetic nephropathy.
- In high glucose-treated mouse podocytes, CASC2 expression decreased while JNK1 phosphorylation increased.
- Overexpression of CASC2 in podocytes inhibited apoptosis and reduced JNK1 phosphorylation.
Conclusions:
- Long non-coding RNA CASC2 is downregulated in diabetic nephropathy.
- Serum CASC2 levels may serve as a diagnostic biomarker for diabetic nephropathy.
- CASC2 exerts a protective effect on podocytes by inhibiting the JNK pathway, suggesting CASC2 as a potential therapeutic target for diabetic nephropathy.
More Related Videos
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
00:46Feedback Inhibition
57.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
01:32RNA Splicing
60.7K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.7K
02:53Ribosomal RNA Synthesis
14.9K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.9K
01:29Nursing Code of Ethics
4.6K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.6K